1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fully Automatic Blood Culture Instrument Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Fully Automatic Blood Culture Instrument by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Fully Automatic Blood Culture Instrument by Country/Region, 2018, 2022 & 2029
2.2 Fully Automatic Blood Culture Instrument Segment by Type
2.2.1 Portable Incubator
2.2.2 Floor Mounted Cultivator
2.3 Fully Automatic Blood Culture Instrument Sales by Type
2.3.1 Global Fully Automatic Blood Culture Instrument Sales Market Share by Type (2018-2023)
2.3.2 Global Fully Automatic Blood Culture Instrument Revenue and Market Share by Type (2018-2023)
2.3.3 Global Fully Automatic Blood Culture Instrument Sale Price by Type (2018-2023)
2.4 Fully Automatic Blood Culture Instrument Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.5 Fully Automatic Blood Culture Instrument Sales by Application
2.5.1 Global Fully Automatic Blood Culture Instrument Sale Market Share by Application (2018-2023)
2.5.2 Global Fully Automatic Blood Culture Instrument Revenue and Market Share by Application (2018-2023)
2.5.3 Global Fully Automatic Blood Culture Instrument Sale Price by Application (2018-2023)
3 Global Fully Automatic Blood Culture Instrument by Company
3.1 Global Fully Automatic Blood Culture Instrument Breakdown Data by Company
3.1.1 Global Fully Automatic Blood Culture Instrument Annual Sales by Company (2018-2023)
3.1.2 Global Fully Automatic Blood Culture Instrument Sales Market Share by Company (2018-2023)
3.2 Global Fully Automatic Blood Culture Instrument Annual Revenue by Company (2018-2023)
3.2.1 Global Fully Automatic Blood Culture Instrument Revenue by Company (2018-2023)
3.2.2 Global Fully Automatic Blood Culture Instrument Revenue Market Share by Company (2018-2023)
3.3 Global Fully Automatic Blood Culture Instrument Sale Price by Company
3.4 Key Manufacturers Fully Automatic Blood Culture Instrument Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fully Automatic Blood Culture Instrument Product Location Distribution
3.4.2 Players Fully Automatic Blood Culture Instrument Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Fully Automatic Blood Culture Instrument by Geographic Region
4.1 World Historic Fully Automatic Blood Culture Instrument Market Size by Geographic Region (2018-2023)
4.1.1 Global Fully Automatic Blood Culture Instrument Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Fully Automatic Blood Culture Instrument Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Fully Automatic Blood Culture Instrument Market Size by Country/Region (2018-2023)
4.2.1 Global Fully Automatic Blood Culture Instrument Annual Sales by Country/Region (2018-2023)
4.2.2 Global Fully Automatic Blood Culture Instrument Annual Revenue by Country/Region (2018-2023)
4.3 Americas Fully Automatic Blood Culture Instrument Sales Growth
4.4 APAC Fully Automatic Blood Culture Instrument Sales Growth
4.5 Europe Fully Automatic Blood Culture Instrument Sales Growth
4.6 Middle East & Africa Fully Automatic Blood Culture Instrument Sales Growth
5 Americas
5.1 Americas Fully Automatic Blood Culture Instrument Sales by Country
5.1.1 Americas Fully Automatic Blood Culture Instrument Sales by Country (2018-2023)
5.1.2 Americas Fully Automatic Blood Culture Instrument Revenue by Country (2018-2023)
5.2 Americas Fully Automatic Blood Culture Instrument Sales by Type
5.3 Americas Fully Automatic Blood Culture Instrument Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fully Automatic Blood Culture Instrument Sales by Region
6.1.1 APAC Fully Automatic Blood Culture Instrument Sales by Region (2018-2023)
6.1.2 APAC Fully Automatic Blood Culture Instrument Revenue by Region (2018-2023)
6.2 APAC Fully Automatic Blood Culture Instrument Sales by Type
6.3 APAC Fully Automatic Blood Culture Instrument Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fully Automatic Blood Culture Instrument by Country
7.1.1 Europe Fully Automatic Blood Culture Instrument Sales by Country (2018-2023)
7.1.2 Europe Fully Automatic Blood Culture Instrument Revenue by Country (2018-2023)
7.2 Europe Fully Automatic Blood Culture Instrument Sales by Type
7.3 Europe Fully Automatic Blood Culture Instrument Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fully Automatic Blood Culture Instrument by Country
8.1.1 Middle East & Africa Fully Automatic Blood Culture Instrument Sales by Country (2018-2023)
8.1.2 Middle East & Africa Fully Automatic Blood Culture Instrument Revenue by Country (2018-2023)
8.2 Middle East & Africa Fully Automatic Blood Culture Instrument Sales by Type
8.3 Middle East & Africa Fully Automatic Blood Culture Instrument Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fully Automatic Blood Culture Instrument
10.3 Manufacturing Process Analysis of Fully Automatic Blood Culture Instrument
10.4 Industry Chain Structure of Fully Automatic Blood Culture Instrument
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fully Automatic Blood Culture Instrument Distributors
11.3 Fully Automatic Blood Culture Instrument Customer
12 World Forecast Review for Fully Automatic Blood Culture Instrument by Geographic Region
12.1 Global Fully Automatic Blood Culture Instrument Market Size Forecast by Region
12.1.1 Global Fully Automatic Blood Culture Instrument Forecast by Region (2024-2029)
12.1.2 Global Fully Automatic Blood Culture Instrument Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fully Automatic Blood Culture Instrument Forecast by Type
12.7 Global Fully Automatic Blood Culture Instrument Forecast by Application
13 Key Players Analysis
13.1 Becton, Dickinson and Company
13.1.1 Becton, Dickinson and Company Company Information
13.1.2 Becton, Dickinson and Company Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.1.3 Becton, Dickinson and Company Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Becton, Dickinson and Company Main Business Overview
13.1.5 Becton, Dickinson and Company Latest Developments
13.2 bioMérieux SA
13.2.1 bioMérieux SA Company Information
13.2.2 bioMérieux SA Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.2.3 bioMérieux SA Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 bioMérieux SA Main Business Overview
13.2.5 bioMérieux SA Latest Developments
13.3 Thermo Fisher Scientific Inc.
13.3.1 Thermo Fisher Scientific Inc. Company Information
13.3.2 Thermo Fisher Scientific Inc. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Inc. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Thermo Fisher Scientific Inc. Main Business Overview
13.3.5 Thermo Fisher Scientific Inc. Latest Developments
13.4 Siemens Healthineers AG
13.4.1 Siemens Healthineers AG Company Information
13.4.2 Siemens Healthineers AG Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.4.3 Siemens Healthineers AG Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Siemens Healthineers AG Main Business Overview
13.4.5 Siemens Healthineers AG Latest Developments
13.5 Roche Diagnostics
13.5.1 Roche Diagnostics Company Information
13.5.2 Roche Diagnostics Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.5.3 Roche Diagnostics Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Roche Diagnostics Main Business Overview
13.5.5 Roche Diagnostics Latest Developments
13.6 Bruker Corporation
13.6.1 Bruker Corporation Company Information
13.6.2 Bruker Corporation Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.6.3 Bruker Corporation Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bruker Corporation Main Business Overview
13.6.5 Bruker Corporation Latest Developments
13.7 Copan Italia S.p.A.
13.7.1 Copan Italia S.p.A. Company Information
13.7.2 Copan Italia S.p.A. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.7.3 Copan Italia S.p.A. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Copan Italia S.p.A. Main Business Overview
13.7.5 Copan Italia S.p.A. Latest Developments
13.8 Liofilchem s.r.l.
13.8.1 Liofilchem s.r.l. Company Information
13.8.2 Liofilchem s.r.l. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.8.3 Liofilchem s.r.l. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Liofilchem s.r.l. Main Business Overview
13.8.5 Liofilchem s.r.l. Latest Developments
13.9 TSC Srl
13.9.1 TSC Srl Company Information
13.9.2 TSC Srl Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.9.3 TSC Srl Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 TSC Srl Main Business Overview
13.9.5 TSC Srl Latest Developments
13.10 HiMedia Laboratories Pvt. Ltd.
13.10.1 HiMedia Laboratories Pvt. Ltd. Company Information
13.10.2 HiMedia Laboratories Pvt. Ltd. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.10.3 HiMedia Laboratories Pvt. Ltd. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HiMedia Laboratories Pvt. Ltd. Main Business Overview
13.10.5 HiMedia Laboratories Pvt. Ltd. Latest Developments
13.11 Biocare Medical, LLC
13.11.1 Biocare Medical, LLC Company Information
13.11.2 Biocare Medical, LLC Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.11.3 Biocare Medical, LLC Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biocare Medical, LLC Main Business Overview
13.11.5 Biocare Medical, LLC Latest Developments
13.12 Hardy Diagnostics
13.12.1 Hardy Diagnostics Company Information
13.12.2 Hardy Diagnostics Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.12.3 Hardy Diagnostics Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hardy Diagnostics Main Business Overview
13.12.5 Hardy Diagnostics Latest Developments
13.13 Merck KGaA
13.13.1 Merck KGaA Company Information
13.13.2 Merck KGaA Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.13.3 Merck KGaA Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Merck KGaA Main Business Overview
13.13.5 Merck KGaA Latest Developments
13.14 Nanomix, Inc.
13.14.1 Nanomix, Inc. Company Information
13.14.2 Nanomix, Inc. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.14.3 Nanomix, Inc. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Nanomix, Inc. Main Business Overview
13.14.5 Nanomix, Inc. Latest Developments
13.15 Osmetech plc
13.15.1 Osmetech plc Company Information
13.15.2 Osmetech plc Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.15.3 Osmetech plc Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Osmetech plc Main Business Overview
13.15.5 Osmetech plc Latest Developments
13.16 SGM Italia s.r.l.
13.16.1 SGM Italia s.r.l. Company Information
13.16.2 SGM Italia s.r.l. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.16.3 SGM Italia s.r.l. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 SGM Italia s.r.l. Main Business Overview
13.16.5 SGM Italia s.r.l. Latest Developments
13.17 Symbiosis Pharmaceutical Services
13.17.1 Symbiosis Pharmaceutical Services Company Information
13.17.2 Symbiosis Pharmaceutical Services Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.17.3 Symbiosis Pharmaceutical Services Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Symbiosis Pharmaceutical Services Main Business Overview
13.17.5 Symbiosis Pharmaceutical Services Latest Developments
13.18 Tetracore, Inc.
13.18.1 Tetracore, Inc. Company Information
13.18.2 Tetracore, Inc. Fully Automatic Blood Culture Instrument Product Portfolios and Specifications
13.18.3 Tetracore, Inc. Fully Automatic Blood Culture Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Tetracore, Inc. Main Business Overview
13.18.5 Tetracore, Inc. Latest Developments
14 Research Findings and Conclusion
※参考情報 全自動式血液培養装置は、感染症診断において重要な役割を果たす医療機器であり、特に血液中の微生物の検出を迅速かつ正確に行うために設計されています。この装置は、試料を自動的に培養し、微生物の成長をモニタリングすることで、感染症の早期発見に貢献します。以下に全自動式血液培養装置の概念や特徴、種類、用途、関連技術などについて詳しく説明します。 全自動式血液培養装置の定義は、血液中に存在する細菌や真菌などの微生物を培養し、その存在を検出するために自動化されたシステムを指します。これらの装置は、臨床検査室で使用され、医療従事者が手動で行う培養プロセスを簡略化し、効率を向上させることを目的としています。これにより、感染の診断、治療の決定、さらには患者の予後の改善に寄与します。 特徴としては、まず自動化されたプロセスがあります。全自動式血液培養装置は、試料の投入から培養、検出までの一連の工程を自動で行うため、作業の手間を大幅に削減します。また、多くの装置にはセンサーやモニタリングシステムが組み込まれており、微生物の成長をリアルタイムで監視することができます。この機能により、陽性反応があった場合にはすぐにアラートが発せられ、迅速な対応が可能になります。 全自動式血液培養装置は、一般的に以下のような種類があります。まず、容器式血液培養装置があります。このタイプでは、血液を培養するための特別なボトルが使用され、各ボトル内の環境が厳密に制御されます。次に、システム内でサンプルを直接取り扱うことができるインライン型血液培養装置も存在します。これにより、ボトルの取り扱いや交換の手間を省くことができます。 用途としては、感染症の診断が最も大きな目的です。全自動式血液培養装置は、特に菌血症や敗血症などの重篤な感染症を早期に発見するために用いられます。感染症の診断が遅れると、適切な治療が行えず、患者の生命に関わる重篤な事態を引き起こす可能性があるため、この装置の役割は極めて重要です。さらに、妊婦や免疫抑制状態にある患者、外科手術後の患者など、感染リスクが高い場合にも広く利用されています。 関連技術としては、分子生物学的手法や質量分析技術が挙げられます。特に、PCR(ポリメラーゼ連鎖反応)や次世代シーケンシング技術は、血液培養の結果を迅速に解釈するためのツールとして注目を浴びています。これらの技術を用いることで、従来の培養法に比べて迅速に病原微生物を特定することが可能となり、診断能力が一層向上します。 さらに、全自動式血液培養装置はデータ管理システムとも密接に関連しています。患者データや培養結果をデジタル化し、病院の電子カルテシステムと連携することで、診断と治療に対する迅速な意思決定をサポートします。これにより、ナースや医師がリアルタイムで培養の進捗状況を把握し、さらに適切な治療方針を選択する手助けとなるのです。 全自動式血液培養装置は、さまざまな医療機関での感染症管理の向上に寄与しています。今後も技術の進展により、より高速かつ精度の高い診断が期待されており、感染症との戦いにおいてますます重要な存在となるでしょう。また、新興感染症や抗菌薬耐性菌に対応するための研究・開発も進められ、これらの装置の機能はますます多様化することが予想されます。 総じて、全自動式血液培養装置は、感染症診断の現場において貴重な役割を果たす重要な医療機器です。その自動化されたプロセスやリアルタイムでの成長モニタリング、関連する先進的な技術との統合は、感染症診断の効率性と精度を大幅に向上させる要因となっています。今後のさらなる技術革新により、より迅速で正確な感染症診断の実現が期待されます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/